|
EP1978095A1
(en)
|
1993-02-12 |
2008-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptor proteins for controlling signal transduction and ligands binding thereto
|
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
|
WO1996041865A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamcycin-based regulation of biological events
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
AU9036198A
(en)
|
1997-08-26 |
1999-03-16 |
Ariad Gene Therapeutics, Inc. |
Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
|
|
EP1003886A1
(en)
|
1997-08-27 |
2000-05-31 |
Ariad Gene Therapeutics, Inc. |
Chimeric transcriptional activators and compositions and uses related thereto
|
|
CA2318402A1
(en)
|
1998-01-15 |
1999-07-22 |
Ariad Gene Therapeutics, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
|
EP1053241A1
(en)
|
1998-02-13 |
2000-11-22 |
President And Fellows Of Harvard College |
Novel dimerizing agents, their production and use
|
|
EP2369002A1
(en)
|
1999-08-09 |
2011-09-28 |
Targeted Genetics Corporation |
Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
CA2388432A1
(en)
|
1999-10-21 |
2001-04-26 |
Monsanto Company |
Post-translational modification of recombinant proteins produced in plants
|
|
GB2362884A
(en)
|
2000-05-30 |
2001-12-05 |
Isis Innovation |
Extended duration of airway gene therapy
|
|
CN1461342A
(zh)
|
2000-07-26 |
2003-12-10 |
路德维格癌症研究所 |
糖基化vegf－b和增加可溶性vegf－b量的方法
|
|
SG10202108118RA
(en)
|
2001-11-13 |
2021-08-30 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
ES2975413T3
(es)
|
2001-12-17 |
2024-07-05 |
Univ Pennsylvania |
Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas
|
|
WO2003068801A2
(en)
|
2002-02-11 |
2003-08-21 |
Genentech, Inc. |
Antibody variants with faster antigen association rates
|
|
US20040208847A1
(en)
|
2003-03-28 |
2004-10-21 |
Fabienne Rolling |
Method and vectors for selectively transducing retinal pigment epithelium cells
|
|
HUE054805T2
(hu)
|
2003-09-30 |
2021-09-28 |
Univ Pennsylvania |
Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
|
|
EP3085389A1
(en)
|
2005-04-07 |
2016-10-26 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
WO2006132118A1
(ja)
|
2005-06-09 |
2006-12-14 |
Matsushita Electric Industrial Co., Ltd. |
振幅誤差補償装置及び直交度誤差補償装置
|
|
CN105315323A
(zh)
|
2007-10-30 |
2016-02-10 |
健泰科生物技术公司 |
通过阳离子交换层析进行的抗体纯化
|
|
TWI580694B
(zh)
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
抗-ｖｅｇｆ抗體
|
|
KR101010352B1
(ko)
|
2008-05-30 |
2011-01-25 |
삼성중공업 주식회사 |
전력 제어 장치 및 방법
|
|
WO2010054007A1
(en)
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
BRPI1012321A8
(pt)
|
2009-06-17 |
2016-09-27 |
Abbott Biotherapeutics Corp |
Anticorpos anti-vegf e seus usos
|
|
US8628966B2
(en)
|
2010-04-30 |
2014-01-14 |
City Of Hope |
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
CN107828820B
(zh)
|
2010-10-27 |
2022-06-07 |
学校法人自治医科大学 |
用于向神经系统细胞导入基因的腺相关病毒粒子
|
|
US9409953B2
(en)
|
2011-02-10 |
2016-08-09 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
CN107012171B
(zh)
|
2011-04-22 |
2021-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
EP2559443A1
(en)
|
2011-08-16 |
2013-02-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
|
|
EP3147295B2
(en)
|
2011-08-24 |
2023-11-22 |
The Board of Trustees of the Leland Stanford Junior University |
New avv capsid proteins for nucleic acid transfer
|
|
US20130090375A1
(en)
|
2011-10-06 |
2013-04-11 |
Cornell University |
Virus-mediated delivery of bevacizumab for therapeutic applications
|
|
EP3470523A1
(en)
|
2012-05-09 |
2019-04-17 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
KR102467714B1
(ko)
|
2012-11-08 |
2022-11-16 |
클리어사이드 바이오메디컬, 인코포레이드 |
인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
|
|
ES2741502T3
(es)
|
2013-02-08 |
2020-02-11 |
Univ Pennsylvania |
Cápside de AAV8 modificada para la transferencia génica para terapias de retina
|
|
CA2905952A1
(en)
|
2013-03-13 |
2014-10-02 |
The Children's Hospital Of Philadelphia |
Adeno-associated virus vectors and methods of use thereof
|
|
JP6591956B2
(ja)
|
2013-03-15 |
2019-10-16 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ｍｐｓ１を治療するための組成物および方法
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
NZ718926A
(en)
|
2013-10-11 |
2021-12-24 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
|
AU2014359276B2
(en)
|
2013-12-03 |
2021-01-28 |
Hookipa Biotech Gmbh |
CMV vaccines
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
US10746742B2
(en)
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
CA2946392A1
(en)
|
2014-04-25 |
2015-10-29 |
James M. Wilson |
Ldlr variants and their use in compositions for reducing cholesterol levels
|
|
MY186389A
(en)
|
2014-05-13 |
2021-07-22 |
Univ Pennsylvania |
Compositions comprising aav expressing dual antibody constructs and uses thereof
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US10064752B2
(en)
|
2014-09-11 |
2018-09-04 |
Orbit Biomedical Limited |
Motorized suprachoroidal injection of therapeutic agent
|
|
CN108347932B
(zh)
|
2015-02-20 |
2022-09-13 |
衣阿华大学研究基金会 |
用于治疗遗传性眼病的方法和组合物
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
JP2018526003A
(ja)
|
2015-08-31 |
2018-09-13 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
イヌの癌を治療するためのキメラａａｖ−抗ｖｅｇｆ
|
|
GB201519086D0
(en)
|
2015-10-28 |
2015-12-09 |
Syncona Partners Llp |
Gene Therapy
|
|
EP3400014A1
(en)
|
2016-01-08 |
2018-11-14 |
Clearside Biomedical, Inc. |
Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
|
|
SG11201808440YA
(en)
|
2016-04-15 |
2018-10-30 |
Regenxbio Inc |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
WO2017180936A1
(en)
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
CA3076905A1
(en)
|
2017-09-27 |
2019-04-04 |
The Johns Hopkins University |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
MX2021011889A
(es)
|
2019-04-03 |
2021-10-26 |
Regenxbio Inc |
Tratamiento genico para patologias oculares.
|